United States
Print page content Print
Increase text size Decrease text size
Text Size

LINCOMIX® Injectable

(lincomycin hydrochloride)

LINCOMIX Injectable Solution is indicated for the treatment of infectious forms of arthritis caused by organisms sensitive to its activity. This includes most of the organisms responsible for the various infectious arthritides in swine, such as the staphylococci, streptococci, Erysipelothrix and Mycoplasma spp.

It is also indicated for the treatment of mycoplasmal pneumonia.

Important Safety Information

The preslaughter withdrawal period for LINCOMIX® (lincomycin hydrochloride) Injectable Solution is 48 hours.